← Eichor
Condition: Letermovir Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Letermovir

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patien
Phase 3 · 29 location(s) · Children's Oncology Group · NCT05711667The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Ce
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT06639854Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
Phase 4 · 12 location(s) · WeiShi · NCT07569653Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections
Phase 3 · 5 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06334497Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lu
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07235683Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogenei
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06812598Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05446571Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
Phase 4 · 1 location(s) · Tufts Medical Center · NCT05626530Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
Phase 2 · 1 location(s) · University of Pennsylvania · NCT06066957Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
Phase 3 · 1 location(s) · University of Wisconsin, Madison · NCT06407232Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy
Phase 2 · 1 location(s) · Seoul National University Hospital · NCT06920251A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
Phase 1 · 18 location(s) · Merck Sharp & Dohme LLC · NCT07199465CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT
Phase 2 · 1 location(s) · University of California, Irvine · NCT06453460Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Phase 2/Phase 3 · 2 location(s) · Columbia University · NCT07079735Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-A
NA · 1 location(s) · Beijing Children's Hospital · NCT07488728Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients
Phase 2 · 1 location(s) · University Medical Centre Ljubljana · NCT05432778Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06575374
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.